Arizalera

Leaflet accompanying the packaging: patient information

Aryzalera, 5 mg, tablets

Aryzalera, 10 mg, tablets

Aryzalera, 15 mg, tablets

Aryzalera, 30 mg, tablets

Aripiprazole

Read the leaflet carefully before taking the medicine, as it contains important information for the patient.

• This leaflet should be kept, so that it can be read again if necessary.
• In case of any doubts, the doctor or pharmacist should be consulted.
• This medicine has been prescribed to a specific person. It should not be given to others. The medicine may harm another person, even if the symptoms of their illness are the same.
• If the patient experiences any side effects, including those not listed in this leaflet, they should inform the doctor or pharmacist. See section 4.

Table of contents of the leaflet

• 1. What is Aryzalera and what is it used for
• 2. Important information before taking Aryzalera
• 3. How to take Aryzalera
• 4. Possible side effects
• 5. How to store Aryzalera
• 6. Contents of the packaging and other information

1. What is Aryzalera and what is it used for

Aryzalera contains the active substance aripiprazole and belongs to a group of antipsychotic medicines.
Aryzalera is used to treat adults and adolescents aged 15 years and older with a disease characterized by symptoms such as: seeing, hearing, and feeling things that are not real, suspiciousness, false beliefs, chaotic speech and behavior, and emotional numbness. Patients with these symptoms may also experience sadness, guilt, anxiety, or tension.
Aryzalera is used to treat adults and adolescents aged 13 years and older whose disease is characterized by symptoms such as: excitement, having too much energy, needing much less sleep than usual, very fast speech with racing thoughts, and sometimes severe irritability. In adults, this medicine also prevents the recurrence of these symptoms in patients who have responded to treatment with Aryzalera.

2. Important information before taking Aryzalera

When not to take Aryzalera

• if the patient is allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Before starting treatment with Aryzalera, the doctor should be consulted.
During treatment with aripiprazole, suicidal thoughts and behaviors have been reported. The doctor should be informed immediately if thoughts or feelings related to self-harm occur.
Before starting treatment with Aryzalera, the doctor should be informed if the patient has:

• high blood sugar levels (characterized by excessive thirst, urination, increased appetite, and feeling of weakness) or a family history of diabetes;
• seizures (epilepsy), as this may mean that the doctor will want to monitor the patient very closely;
• involuntary, irregular muscle movements, especially of the face;
• heart and blood vessel diseases, a family history of heart and blood vessel diseases, stroke, or "mini" stroke, abnormal blood pressure;
• blood clots or a history of blood clots, as the use of antipsychotic medicines is associated with their formation;
• a history of gambling addiction.

If the patient notices an increase in weight, appearance of unusual movements, drowsiness that interferes with daily activities, any difficulty swallowing, or symptoms of an allergic reaction, they should inform the doctor.
If an elderly patient with dementia is being treated, their caregiver or relative should inform the doctor if the patient has ever had a stroke or "mini" stroke.
The doctor should be informed immediately if thoughts or feelings related to self-harm occur. During treatment with aripiprazole, suicidal thoughts and behaviors have been reported.
The doctor should be informed immediately if the patient experiences muscle stiffness or stiffness with high fever, excessive sweating, mental disorders, or very fast or irregular heartbeat.
If the patient or their family or caregiver notices that the patient starts to feel the urge or desire to behave in an unusual way and cannot resist the impulse, urge, or temptation to engage in activities that may harm them or others, they should tell the doctor. These phenomena are called impulse control disorders and may manifest as behaviors such as compulsive gambling, overeating, or excessive spending, increased sexual drive, or increased frequency and intensity of thoughts or feelings about sexual topics.
The doctor may consider changing the dose or discontinuing the medicine.
Aripiprazole may cause drowsiness, decreased blood pressure when standing up, dizziness, and changes in mobility and balance, which may lead to falls. Caution should be exercised, especially in elderly or weakened patients.

Children and adolescents

Aryzalera should not be used in children and adolescents under 13 years of age. It is not known if the use of this medicine is safe and effective in these patients.

Aryzalera and other medicines

The doctor or pharmacist should be told about all medicines the patient is currently taking or has recently taken, as well as any medicines the patient plans to take, including those available without a prescription.
Blood pressure-lowering medicines: Aryzalera may enhance the effects of blood pressure-lowering medicines. If the patient is taking blood pressure-lowering medicines, they should inform their doctor.
The use of Aryzalera with certain medicines may require a change in the dose of Aryzalera or other medicines taken by the patient. It is especially important to inform the doctor about the use of the following medicines:

• medicines used to treat heart rhythm disorders (such as quinidine, amiodarone, flecainide);
• antidepressant medicines or herbal medicines used to treat depression and anxiety (such as fluoxetine, paroxetine, venlafaxine, St. John's Wort);
• antifungal medicines (such as ketoconazole, itraconazole);
• certain medicines used to treat HIV infection (such as efavirenz, nevirapine, protease inhibitors, e.g., indinavir, ritonavir);
• antiepileptic medicines used to treat epilepsy (such as carbamazepine, phenytoin, phenobarbital);
• certain antibiotics used to treat tuberculosis (rifabutin, rifampicin).

Taking these medicines may increase the risk of side effects or decrease the effect of Aryzalera. If the patient experiences any unusual symptoms while taking these medicines with Aryzalera, they should inform their doctor.
Medicines that increase serotonin levels are usually used to treat depression, generalized anxiety disorder, obsessive-compulsive disorder (OCD), and social phobia, as well as migraine and pain:

• triptans, tramadol, and tryptophan used to treat depression, generalized anxiety disorder, obsessive-compulsive disorder (OCD), and social phobia, as well as migraine and pain;
• selective serotonin reuptake inhibitors (SSRIs) (such as paroxetine and fluoxetine) used to treat depression, OCD, panic, and anxiety;
• other antidepressant medicines (such as venlafaxine and tryptophan) used to treat severe depression;
• tricyclic antidepressant medicines (such as clomipramine and amitriptyline) used to treat depression;
• St. John's Wort (Hypericum perforatum) used as a herbal preparation for mild depression;
• pain relievers (such as tramadol and pethidine) used to relieve pain;
• triptans (such as sumatriptan and zolmitriptan) used to treat migraine.

Taking these medicines may increase the risk of side effects. If the patient experiences any unusual symptoms while taking these medicines with Aryzalera, they should inform their doctor.

Aryzalera with food, drink, and alcohol

The medicine can be taken with or without food.
Alcohol should not be consumed during treatment with Aryzalera.

Pregnancy, breastfeeding, and fertility

If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor before taking this medicine.
In newborns whose mothers took Aryzalera during the last trimester of pregnancy (the last 3 months of pregnancy), the following symptoms may occur: trembling, muscle stiffness, and/or weakness, drowsiness, agitation, breathing difficulties, and feeding difficulties. If such symptoms are observed in the child, the doctor should be consulted.
If the patient is taking Aryzalera, the doctor will discuss with them whether they should breastfeed, considering the benefits of treatment and the benefits of breastfeeding. The medicine should not be taken and the child breastfed at the same time. The doctor should be consulted about the best methods of feeding the child if the patient is taking this medicine.

Driving and using machines

Dizziness and vision disturbances may occur during treatment with this medicine (see section 4).
This should be taken into account when performing tasks that require full attention, such as driving or operating machinery.

Aryzalera contains lactose

If the patient has been diagnosed with an intolerance to some sugars, they should consult their doctor before taking this medicine.

3. How to take Aryzalera

This medicine should always be taken as directed by the doctor or pharmacist. In case of doubts, the doctor or pharmacist should be consulted.
The recommended dose for adults is 15 mg once a day.However, the doctor may prescribe a lower or higher dose, which should not exceed 30 mg once a day.

Use in children and adolescents

Aripiprazole treatment can be started with a low dose of aripiprazole oral solution (liquid). The dose may be gradually increased to a recommended dose for adolescents of 10 mg once a day. However, the doctor may prescribe a lower or higher dose, up to a maximum of 30 mg once a day.
If the patient feels that the effect of the medicine is too strong or too weak, they should consult their doctor or pharmacist.
Aryzalera is intended for oral use.
Aryzalera should be taken every day at the same time. It does not matter whether the tablet is taken with or without food. The tablet should be swallowed whole and washed down with water.
Even if the patient feels better,the dose of Aryzalera should not be changed or the treatment discontinued without consulting the doctor.

Overdose of Aryzalera

In case of taking a higher dose than prescribed by the doctor (or if someone else has taken some of the medicine not intended for them), the doctor should be consulted immediately. If it is difficult to contact the doctor, the patient should go to the nearest hospital, taking the packaging of the medicine with them.
In patients who have taken too much aripiprazole, the following symptoms have occurred:

• rapid heartbeat, agitation/aggression, speech problems;
• unusual body movements (especially of the face or tongue) and decreased consciousness.

Other symptoms include:

• severe confusion, seizures (epilepsy), coma, simultaneous occurrence of fever, rapid breathing, and excessive sweating;
• muscle stiffness and drowsiness or lethargy, slow breathing, choking, high or low blood pressure, irregular heartbeat.

If the patient experiences any of these symptoms, they should contact their doctor or hospital immediately.

Missed dose of Aryzalera

If a dose is missed, the patient should take the missed dose as soon as they remember. Two doses should not be taken on the same day.

Discontinuation of Aryzalera

Treatment should not be discontinued just because the patient feels better. It is very important to take Aryzalera as directed by the doctor and for the period prescribed by the doctor.
In case of any further doubts about the use of this medicine, the doctor or pharmacist should be consulted.

4. Possible side effects

Like all medicines, Aryzalera can cause side effects, although not everybody gets them.
Common side effects (may affect up to 1 in 10 people):

• diabetes,
• sleep disturbances,
• feeling anxious,
• feeling restless and unable to sit or stand still,
• akathisia (feeling of inner restlessness and compulsion to perform continuous movements),
• uncontrolled trembling, jerking movements, or writhing movements,
• trembling,
• headache,
• fatigue,
• drowsiness,
• feeling of "emptiness" in the head,
• blurred vision and double vision,
• decreased number of bowel movements or difficulty with bowel movements,
• nausea,
• vomiting,
• excessive salivation,
• feeling tired.

Uncommon side effects (may affect up to 1 in 100 people):

• decreased or increased prolactin levels in the blood,
• high blood sugar levels,
• depression,
• changes in sexuality or increased interest in sex,
• uncontrolled movements of the mouth, tongue, and limbs (tardive dyskinesia),
• muscle disorders causing twisting movements (dystonia),
• restless legs syndrome
• double vision,
• eye sensitivity to light,
• rapid heartbeat,
• decreased blood pressure when standing up, causing dizziness, feeling of "emptiness" in the head, or fainting,
• hiccups.

The following side effects have been reported after the marketing of aripiprazole, but their frequency is not known:

• decreased white blood cell count,
• decreased platelet count,
• allergic reactions (e.g., swelling of the mouth, tongue, face, and throat, itching, rash),
• onset of diabetes or worsening of its course, ketoacidosis (presence of ketone bodies in the blood and urine), or coma,
• high blood sugar levels,
• low sodium levels in the blood,
• loss of appetite (anorexia),
• weight loss,
• weight gain,
• suicidal thoughts, attempted suicide, and completed suicide,
• feeling aggressive,
• agitation,
• nervousness,
• simultaneous occurrence of fever, muscle stiffness, rapid breathing, sweating, decreased consciousness, and sudden changes in blood pressure and heart rate, fainting (neuroleptic malignant syndrome),
• seizures,
• serotonin syndrome (a reaction that can cause feelings of great happiness, drowsiness, clumsiness, restlessness, especially motor restlessness, feeling of intoxication, fever, sweating),
• speech disorders,
• fixation of the eyeballs in one position,
• sudden unexplained death,
• life-threatening irregular heartbeat,
• heart attack (myocardial infarction),
• slow heartbeat,
• blood clots in the veins, especially in the legs (symptoms include swelling, pain, and redness of the legs), which can travel through the blood vessels to the lungs, causing chest pain and breathing difficulties (if the patient experiences any of these symptoms, they should see a doctor immediately),
• high blood pressure,
• fainting,
• accidental choking on food with a risk of pneumonia,
• muscle spasm around the vocal cords,
• pancreatitis,
• difficulty swallowing,
• diarrhea,
• abdominal discomfort,
• stomach discomfort,
• liver failure,
• hepatitis,
• jaundice,
• abnormal liver test results,
• skin rash,
• skin sensitivity to light,
• hair loss,
• excessive sweating,
• severe allergic reactions, such as drug rash with eosinophilia and systemic symptoms (DRESS syndrome). Initially, DRESS syndrome resembles flu-like symptoms with a rash on the face, and then a rash appears on other parts of the body, high fever, swollen lymph nodes, elevated liver enzyme activity (visible in blood tests), and elevated levels of a certain type of white blood cell (eosinophilia),
• abnormal breakdown of muscle leading to kidney problems,
• muscle pain,
• stiffness,
• involuntary urination (incontinence),
• difficulty urinating,
• withdrawal syndrome in newborns in case of exposure to the medicine during pregnancy,
• prolonged and/or painful erection,
• difficulty regulating body temperature or overheating,
• chest pain,
• swelling of the hands, ankles, or feet,
• in blood tests: fluctuations in blood sugar levels, increased glycated hemoglobin levels,
• inability to resist the impulse, urge, or temptation to engage in activities that may harm the patient or others, including behaviors such as:
• strong impulse to gamble excessively despite significant personal or family consequences,
• changed or increased interest in sex and behaviors that significantly disturb the patient or others, such as increased sexual drive,
• uncontrolled excessive shopping or spending,
• uncontrolled overeating or compulsive eating (eating larger amounts of food than usual and more than needed to satisfy hunger),
• urge to wander. If the patient experiences such behaviors, they should tell their doctor, who will discuss ways to treat or reduce these symptoms.

In elderly patients with dementia taking aripiprazole, more cases of death have been reported. Additionally, cases of stroke or "mini" stroke have been noted.

Additional side effects in children and adolescents

In adolescents aged 13 years and older, side effects have occurred with a similar frequency and type as in adults, except for drowsiness, uncontrolled trembling or movements, restlessness, and fatigue, which have occurred very frequently (more than 1 in 10 patients), as well as upper abdominal pain, dry mouth, rapid heartbeat, weight gain, increased appetite, muscle tremors, uncontrolled limb movements, and dizziness, especially when standing up from a lying or sitting position, which have occurred frequently (more than 1 in 100 patients).

Reporting side effects

If side effects occur, including those not listed in this leaflet, the doctor or pharmacist should be informed. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.

5. How to store Aryzalera

The medicine should be stored out of sight and reach of children.
The medicine should not be used after the expiration date stated on the packaging after the abbreviation "EXP". The expiration date refers to the last day of the specified month.
The batch number is stated on the packaging after the abbreviation "Lot".
There are no special precautions for storing the medicine.
Medicines should not be disposed of via wastewater or household waste. The pharmacist should be asked how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the packaging and other information

What Aryzalera contains

• The active substance of the medicine is aripiprazole. Each tablet contains 5 mg, 10 mg, 15 mg, or 30 mg of aripiprazole.
• The other ingredients are: lactose monohydrate, cornstarch, microcrystalline cellulose, hydroxypropyl cellulose, iron oxide red (E 172) - only in 10 mg and 30 mg tablets, iron oxide yellow (E 172) - only in 15 mg tablets, indigo carmine lake (E 132) - only in 5 mg tablets, and magnesium stearate. See section 2, "Aryzalera contains lactose".

What Aryzalera looks like and what the pack contains

5 mg, tablets: blue, round tablets with beveled edges, with possible darker and lighter spots (diameter: 5 mm, thickness: 1.4 - 2.4 mm)
10 mg, tablets: light pink, rectangular tablets with possible darker and lighter spots and the symbol "A10" printed on one side (length: 8 mm, width: 4.5 mm, thickness: 2.1 - 3.1 mm)
15 mg, tablets: light yellow to brownish, round, slightly convex tablets with beveled edges, with possible darker and lighter spots and the symbol "A15" printed on one side (diameter: 7.5 mm, thickness: 2.5 - 3.7 mm)
30 mg, tablets: light pink, round, convex tablets with beveled edges, with possible darker and lighter spots and the symbol "A30" printed on one side (diameter: 9 mm, thickness: 3.9 - 5.3 mm)
Packaging:14, 28, 30, 50, 56, 60, 84, 90, 98, and 100 tablets in blisters, in a cardboard box
Not all pack sizes may be marketed.

Marketing authorization holder

KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia

Manufacturer

KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany
To obtain more detailed information about the names of this medicine in other European Economic Area countries, the representative of the marketing authorization holder should be contacted:
KRKA-POLSKA Sp. z o.o.
ul. Równoległa 5
02-235 Warsaw
Phone: 22 57 37 500
Date of last revision of the leaflet:21.04.2023